Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01870869 · ClinicalTrials.gov registry record · NA
NATRELLE® 410 X-Style and L-Style Breast Implants Continued Access Study
A NA study, sponsored by Allergan.
- Terminated
- Registry status
- NA
- Development phase
- 1,951
- Enrollment target
NCT01870869 is a NA study that was terminated before completion, run by Allergan. The registered enrollment target is 1,951 participants.
The verdict
NCT01870869, a NA study, was terminated before completion, sponsored by Allergan.
- TERMINATED
- Registry status
- NA
- Development phase
- 1,951 participants
- Enrollment target
Study Summary
This study is a prospective, multicenter, nonrandomized study to provide access to and evaluate the safety and effectiveness of NATRELLE® 410 Highly Cohesive Anatomically Shaped Silicone-Filled X-Style and L-Style Breast Implants for breast augmentation, reconstruction, or revision.
Interventions
- DEVICE Anatomically shaped, silicone-filled breast implants with low height/projection or extra-full projection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,951 participants |
| Start Date | 2013-05-29 |
| Est. Completion | 2015-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01870869
The ClinicalTrials.gov registry entry for NCT01870869 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1,951 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Anatomically shaped, silicone-filled breast implants with low height/projection or extra-full projection is the first listed.
NCT01870869 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01870869 about?
NCT01870869 is a clinical study titled "NATRELLE® 410 X-Style and L-Style Breast Implants Continued Access Study". This study is a prospective, multicenter, nonrandomized study to provide access to and evaluate the safety and effectiveness of NATRELLE® 410 Highly Cohesive Anatomically Shaped Silicone-Filled X-Style and L-Style Breast Implants for breast augmentation, reconstruction, or revision.
What is the current status of trial NCT01870869?
This trial is currently terminated. It is a NA study. The enrollment target is 1,951 participants. The study started on 2013-05-29. Estimated completion is 2015-11-30.
What interventions are being tested in trial NCT01870869?
The interventions under investigation include: Anatomically shaped, silicone-filled breast implants with low height/projection or extra-full projection (DEVICE).
Who is sponsoring clinical trial NCT01870869?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.